Skip to main content

Table 3 Opiate use characteristics by presence and severity of opioid use disorder

From: Prevalence and determinants of opioid use disorder among long-term opiate users in Golestan Cohort Study

Opiate use characteristics

Opiate users w/o

Disorder

(N = 190)

Opioid use disorder

P for trend by severity†

All

(N = 261)

Mild

(N = 144)

Moderate

(N = 71)

Severe

(N = 46)

Age of start opiate use (Mean ± SD)

38.8 ± 12.6

35.1 ± 12.4**

37.9 ± 13.0

32.7 ± 11.0

30.1 ± 9.9

< 0.001

Current opiate dose, n (%) (gram per week) a

Q1 (< 1.4)

92 (49.4)

63 (24.7)**

38 (26.7)

12 (17.1)

13 (30.2)

0.049

Q2 (1.4–2.8)

34 (18.2)

52 (20.3)

33 (23.2)

16 (22.8)

3 (6.9)

Q3 (2.8-7.0)

39 (20.9)

71 (27.8)

40 (28.1)

23 (32.8)

8 (18.6)

Q4 (> 7.0)

21 (11.2)

69 (27.0)

31 (21.8)

19 (27.1)

19 (44.1)

Prior opiate dose, n (%) (gram per week) b

Q1 (< 0.6)

6 (35.5)

55 (21.4)**

37 (26.2)

12 (17.1)

6 (13.3)

< 0.001

 

Q2 (0.6–2.8)

56 (30.6)

85 (33.2)

54 (38.3)

21 (30.0)

10 (22.2)

 

Q3 (2.8–10.5)

32 (17.4)

46 (17.9)

22 (15.6)

13 (18.5)

11 (24.4)

 

Q4 (> 10.5)

30 (16.3)

70 (27.3)

28 (19.8)

24 (34.2)

18 (40.0)

Change in dose (gram/week), mean (SD) c

 

0.13 (4.6)

1.7 (4.9)**

2.1 (4.9)

1.2 (4.7)

1.5 (5.2)

0.15

Current pattern of opiate use, n (%)

Non- daily

38 (20.0)

26 (10.0)**

14 (9.8)

3 (4.3)

9 (19.5)

0.334

Daily

152 (80.0)

235 (90.0)

130 (90.2)

68 (95.7)

37 (80.5)

Prior pattern of opiate use, n (%) b

Non daily

74 (40.4)

80 (31.2)*

49 (34.7)

21 (30.0)

10 (22.2)

0.128

 

Daily

109 (59.5)

176 (68.7)

92 (65.2)

49 (70.0)

35 (77.7)

Current type of the opiate, n (%) d

Opium only

88 (50.2)

109 (46.1)

67 (50.3)

31 (46.2)

11 (30.5)

0.070

Shire ± opium

87 (49.7)

127 (53.1)

66 (49.6)

36 (53.7)

25 (69.4)

Prior type of the opiate, n (%) b

Opium only

162 (88.5)

219 (85.5)

124 (87.9)

59 (84.2)

36 (80.0)

0.180

 

Shire ± opium

21 (11.4)

37 (14.4)

17 (12.0)

11 (15.7)

9 (20.0)

Current route of opiate use, n (%) e

Smoke only

99 (55.3)

82 (33.8)**

51 (37.7)

24 (35.2)

7 (17.9)

< 0.01

Oral only

74 (41.3)

132 (54.5)

73 (54.0)

37 (54.4)

22 (56.4)

Dual

6 (3.3)

28 (11.5)

11 (8.1)

7 (10.2)

10 (25.6)

Prior route of opiate use, n (%) b

Smoke only

146 (79.7)

174 (67.9)*

100 (70.9)

47 (67.1)

27 (60.0)

0.165

 

Oral only

34 (18.5)

74 (28.9)

37 (26.2)

22 (31.4)

15 (33.3)

 

Dual

3 (1.6)

8 (3.1)

4 (2.8)

1 (1.4)

3 (6.6)

Change in route, n (%) d

Still smoke

87 (50.2)

79 (33.1)**

49 (36.8)

24 (35.8)

6 (15.7)

0.075

Still oral

30 (17.3)

72 (30.2)

37 (27.8)

22 (32.8)

13 (34.2)

Change from smoke

50 (28.9)

78 (32.7)

43 (32.3)

20 (29.8)

15 (39.4)

Change from oral

6 (3.4)

9 (3.7)

4 (3.0)

1 (1.4)

4 (10.5)

  1. SD: standard deviation, BMI: body mass index.
  2. Number of dual users of opium and shireh is 13 in current status and 9 in baseline status.
  3. The missing values are as follows: a = 10, b = 12, c = 38, d = 40, e = 30
  4. * P < 0.05, ** P < 0.01
  5. † Using univariate ordered logistic regression across categories of OUD severity (from mild to severe)